Division of Strategic Planning and Evaluation FY2019 List of Projects - Research Program on Emerging and Re-emerging Infectious Diseases
| First Year | Final Year | Principal Investigator | Affiliation | Project Title | |
|---|---|---|---|---|---|
| FY2017 | FY2019 | Jiro Yasuda | Nagasaki University | Professor | Research and development of therapeutics, diagnostics and preventive measures for containment of viral hemorrhagic fevers |
| FY2017 | FY2019 | Yoshihiro Kawaoka | The University of Tokyo | Professor | Development of next generation Ebola virus vaccines |
| FY2017 | FY2019 | Tsutomu Kageyama | National Institute of Infectious Diseases | Chief | Development of diagnostic function for emerging pandemic influenza viruses and respiratory viruses |
| FY2017 | FY2019 | Shinji Watanabe | National Institute of Infectious Diseases | Chief | Prediction models of novel antigenic variants of seasonal influenza viruses and application for selection of viruses for influenza vaccine |
| FY2017 | FY2019 | Makoto Takeda | National Institute of Infectious Diseases | Director | Research for development of laboratory systems for national and global surveillance for respiratory syncytial virus infection |
| FY2017 | FY2019 | Hirokazu Kimura | Gunma Paz University | Professor | Studies on molecular epidemiology and epidemic prediction of the gastroenteric virus infections |
| FY2017 | FY2019 | Yuichi Someya | National Institute of Infectious Diseases | Senior Researcher | Studies on pathogenesis of diarrheal viruses and development of anti-viral drugs and vaccines |
| FY2017 | FY2019 | Chang-Kweng Lim | National Institute of Infectious Diseases | Chief | Establishing surveillance system for the risk of outbreaks of emerging and re-emerging insect-borne diseases in Japan and developing comprehensive insect-borne virus control system |
| FY2017 | FY2019 | Yoshiharu Matsuura | Osaka University | Director, Professor | Characterization of host factors involved in the propagation and pathogenesis of insect-borne viruses and development of preventive and therapeutic measures targeting these host factors |
| FY2017 | FY2019 | Isao Hamaguchi | National Institute of Infectious Diseases | Director | Epidemiological study regarding HTLV-1 infection and comprehensive effective strategy for its infection inhibition |
| FY2017 | FY2019 | Tetsuro Matano | National Institute of Infectious Diseases | Director | Development of a vaccine against HTLV-1 prevalence and disease progression |
| FY2017 | FY2019 | Kaoru Uchimaru | The University of Tokyo | Professor | Investigation of Putative Common Mechanism of ATL/HAM Development and Clinical Entity of Chronic Active HTLV-1 Infection |
| FY2017 | FY2019 | Akifumi Takaori-Kondo | Kyoto University | Professor | Study on the impaired DNA repair induced by HTLV-1 infection and its role in leukemogenesis and development of a novel therapeutic strategy |
| FY2017 | FY2019 | Seiya Kato | The Research Institute of Tuberculosis, Japan Anti-Tuberculosis Association | Director | Multi-dimensional research on strengthening tuberculosis control program in Japan to accelerate tuberculosis low incidence |
| FY2017 | FY2019 | Toshio Hattori | KIBI International University | Professor | Comprehensive Strategies against Multidrug-Resistant Tuberculosis utilizing Overseas Networks |
| FY2017 | FY2019 | Manabu Ato | National Institute of Infectious Diseases | Director | Establishment of epidemiological investigation, diagnostic tools, and therapeutics of non-tuberculous mycobacteria |
| FY2017 | FY2019 | Tadayoshi Ikebe | National Institute of Infectious Diseases | Senior researcher | Research on the pathogenesis-related factors of streptococcal toxic shock syndrome and research towards development of novel therapeutic methods |
| FY2017 | FY2019 | Yoshitsugu Miyazaki | National Institute of Infectious Diseases | Director | Investigation of breakthrouh innovation for prevalence, novel diagnosis and treatment to overcomethe invasive fungal infection by yeasts |
| FY2017 | FY2019 | Tomoyoshi Nozaki | The University of Tokyo | Professor | Integrated Project on Development of New Diagnostics, Surveillance System, Pathogen Genome Database, and Elucidation of Mechanisms of Drug Resistance, Pathogenesis and Parasitism |
| FY2017 | FY2019 | Masahiro Yamamoto | Osaka University | Professor | Research and Development for Comprehensive Measures against Toxoplasmosis |
| FY2017 | FY2019 | Makoto Kuroda | National Institute of Infectious Diseases | Director | Genomics application for controlling antimicrobial resistant-bacteria using an integrated database of pathogen genomics and epidemiology (GenEpid-J) |
| FY2017 | FY2019 | Makoto Ohnishi | National Institute of Infectious Diseases | Deputy Director-General | Construction of laboratory network among the research institutions for infectious diseases in Asian countries |
| FY2017 | FY2019 | Hiroshi Nishiura | Hokkaido University | Professor | Project organization and implementation of epidemiological modeling studies of infectious diseases for assisting healthcare assosciated policy making |
| FY2017 | FY2019 | Yoshimasa Takahashi | National Institute of Infectious Diseases | Director | Rational design of novel vaccines with improved efficacy and safety |
| FY2017 | FY2019 | Katsunori Yanagihara | Nagasaki University | Professor | Research and development of diagnostic methods and therapies for antimicrobial resistant bacteria |
| FY2017 | FY2019 | Tetsuro Suzuki | Hamamatsu University School of Medicine | Professor | Understanding of dynamics of Zika virus infection and its immune responses in the common marmoset model |
| FY2017 | FY2019 | Yoshitoshi Ogura | Kyushu University | Associate professor | Development of new therapeutic strategy for enterohemorrhagic Escherichia coli infection using Shiga toxin-neutralizing plastic antibody |
| FY2017 | FY2019 | Takeshi Noda | Kyoto University | Professor | Antiviral drug development for Ebola virus disease and Lassa fever |
| FY2018 | FY2020 | Yoshihiro Kawaoka | The University of Tokyo | Professor | Study on risk assessment and vaccine development for highly pathogenic avian H7N9 influenza viruses emerged in China |
| FY2018 | FY2020 | Eri Nobusawa | National Institute of Infectious Diseases | Lab chief | Study of the cell-based influenza vaccine |
| FY2018 | FY2020 | Tsuneo Morishima | Aichi Medical University | Visitng Professor | Research on the diagnosis and treatment of severe respiratory infections caused by viruses |
| FY2018 | FY2020 | Takuo Mizukami | National Institute of Infectious Diseases | Section Chief | Development of hyper-immune-Globulin against HTLV-1 infection and disease progression |
| FY2018 | FY2020 | Yuetsu Tanaka | University of the Ryukyus | Professor | Generation of recombinant human immunoglobulin drugs and verification using a non-human primatemodel for development of passive immunization prophylaxis against mother to child vertical infection with HTLV-1 |
| FY2018 | FY2020 | Keigo Shibayama | National Institute of Infectious Diseases | Director | Research and development of new technologies for comprehensive infection control of emerging and re-emerging Antimicrobial Resistance |
| FY2018 | FY2020 | Makoto Ohnishi | National Institute of Infectious Diseases | Deputy Director-General | Research for control of antimicrobial resistant Neisseria gonorrhoeae infection |
| FY2018 | FY2020 | Satoshi Mitarai | The Research Institute of Tuberculosis, Japan Anti-Tuberculosis Association | Professor/Head | Technology development for tuberculosis infection control with OMICS information |
| FY2018 | FY2020 | Yoshihiko Hoshino | National Institute of Infectious Diseases | Division Chair | Studies toward the development of prophylaxis, diagnosis and treatment of leprosy and other mycobacterial skin diseases |
| FY2018 | FY2020 | Sunao iyoda | National Institute of Infectious Diseases | Chief | Research for the establishment of surveillance method and virulence evaluation system of deiarrheagenic enterobacteria |
| FY2018 | FY2020 | Motoi Suzuki | National Institute of Infectious Diseases | Director | Researches on surveillance for vaccine-preventable diseases and evaluation of vaccine effectiveness |
| FY2018 | FY2020 | Kyoko Sawabe | National Institute of Infectious Diseases | Senior Researcher | Studies of arthropods involved in vector-borne diseases |
| FY2018 | FY2020 | Shuji Ando | National Institute of Infectious Diseases | Chief | Research for syntetic strategy of tick-borne bacterial diseases |
| FY2018 | FY2020 | Ken Maeda | National Institute of Infectious Diseases | Director | Establishment of system for diagnosis and information sharing of zoonosis transmitted by companion animals |
| FY2018 | FY2020 | Shuetsu Fukushi | National Institute of Infectious Diseases | Director | Research on the improvement of the bio-risk management systems of highly pathogenic agents |
| FY2018 | FY2020 | Ryoichi Saito | Tokyo Medical and Dental University | Associate professor | Research and development of effective testing and surveillance strategies for meningococcal disease in mass gatherings |
| FY2018 | FY2020 | Masayuki Saijo | National Institute of Infectious Diseases | Director | Research on the therapeutic and preventive measures against highly pathogenic virus infections: development of vaccines to and animal models of highly pathogenic virus infections |
| FY2018 | FY2020 | Ichiro Nakagawa | Kyoto University | Professor | Construction of optimized antibody production platform for development of new diagnostic and therapeutic drugs against bacterial infections |
| FY2018 | FY2020 | Yasuo Yoshioka | Osaka University | Specially-Appointed Associate Professor | Creation of dendritic cell-targeting peptides as vaccine delivery vehicle for the development of vaccine against infectious diseases |
| FY2018 | FY2020 | Yoshihiko Hoshino | National Institute of Infectious Diseases | Division Chair | The development of novel treatment strategy regarding the functional comprehension of inducible and inhibitory innate receptor under the latency and re-activation of mycobacterial infection |
| FY2018 | FY2020 | Atsushi Kawaguchi | University of Tsukuba | Associate Professor | Molecular basis for mammalian adaptation of emerging influenza virus |
| FY2018 | FY2020 | Ryohei Hirose | Kyoto Prefectural University of Medicine | Assistant Professor | Analysis of the onset mechanism and clinicopathological characteristics of seasonal influenza-related enteritis |
| FY2018 | FY2020 | Yoshiki Fujii | National Institute of Infectious Diseases | Senior Researcher | Molecular epidemiological study of rotaviruses based on full genome analysis after vaccine introduction |
| FY2018 | FY2020 | Shogo Ozaki | Kyushu University | Associate Professor | A novel approach to identify selective inhibitors for microbial biofilms |
| FY2019 | FY2021 | Masayuki Shimojima | National Institute of Infectious Diseases | Chief | Research on diagnosis, treatment, and preventive measures of emerging and re-emerging infectious diseases including viral hemorrhagic fevers |
| FY2019 | FY2021 | Masayuki Saijo | National Institute of Infectious Diseases | Director | Development of preventive measures of severe fever with thrombocytopenia syndrome (SFTS) |
| FY2019 | FY2021 | Noriko Nakajima | National Institute of Infectious Diseases | Chief | International collaborative research on diagnosis and treatment based on clinicopathological study of severe respiratory infections including novel influenza |
| FY2019 | FY2021 | Hideki Hasegawa | National Institute of Infectious Diseases | Director | Establishment of fundamental technologies for clinical use of an intranasal influenza vaccine |
| FY2019 | FY2021 | Hiroyuki Shimizu | National Institute of Infectious Diseases | Chief | Study of the development of diagnostic, therapeutic, and preventive strategies for emerging and re-emerging enterovirus infections |
| FY2019 | FY2021 | Minetaro Arita | National Institute of Infectious Diseases | Senior research scientist | Development of poliovirus neutralization test with poliovirus pseudovirus |
| FY2019 | FY2021 | Yoshio Mori | National Institute of Infectious Diseases | Chief | Study to strengthen the surveillance for measles and rubella |
| FY2019 | FY2021 | Minoru Kidokoro | National Institute of Infectious Diseases | Chief | Study on the development of safe and effective novel mumps vaccines based on both long-term and short-term viewpoint |
| FY2019 | FY2021 | Masao Matsuoka | Kumamoto University | Professor | Predictive strategy of HTLV-1-associated diseases based on host/viral genomic data and development of an integrated database of clinical and genomic Information |
| FY2019 | FY2021 | Toshiki Tamura | National Institute of Infectious Diseases | Laboratory Head | Development of new tools to detect latent TB and high-risk individuals, effective recombinant BCG vaccine and booster vaccine, and new drugs for treatment of multidrug resistant tuberculosis, for global tuberculosis control |
| FY2019 | FY2021 | Naoto Keicho | The Research Institute of Tuberculosis, Japan Anti-Tuberculosis Association | Vice Director | Study on biological factors for prediction of disease risk and shorter treatment of tuberculosis |
| FY2019 | FY2021 | Masuyoshi Saito | Tokyo Medical University | Assistant Professor | Research and development contributing to rapid diagnosis of syphilis |
| FY2019 | FY2021 | Takeshi Murata | Chiba University | Professor | Development of new antibacterial drug targeting V-ATPase in Vancomycin-resistant Enterococcus (VRE) |
| FY2019 | FY2021 | Masato Suzuki | National Institute of Infectious Diseases | Senoir Reseacher | Development of novel antibacterial agents by reevaluating old antibiotics and repositioning approved drugs |
| FY2019 | FY2021 | Shigeru Kohno | Nagasaki University | President | Developmental study of innovative diagnostics and therapeutics against invasive fungal infections, including management of antifungal resistance |
| FY2019 | FY2021 | Haruhiko Maruyama | University of Miyazaki | Professor | Development of optimal medical care network for the diagnosis, treatment, and prevention for tropical and parasitic diseases in Japan |
| FY2019 | FY2021 | Hajime Hisaeda | National Institute of Infectious Diseases | Director | Analyses of CNS pathogenesis by parasites and its application to diagnostic and therapeutic strategies |
| FY2019 | FY2021 | Shigeru Morikawa | Okayama University of Science | Professor | Studies on examination, diagnosis and prevention methods that contribute to control of zoonoses |
| FY2019 | FY2021 | Koji Matsumoto | Showa University School of Medicine | Professor | Study for monitoring the impact of a national HPV vaccination program in Japan (MINT study II) |
| FY2019 | FY2021 | Shigeru Suga | National Hospital Organization Mie National Hospital | Vice Director | Research on vaccine effectiveness and safety in widely vaccinated population and evaluation and development of vaccine |
| FY2019 | FY2021 | Koji Ishii | National Institute of Infectious Diseases | Director | Study of the development and improvement of quality control of vaccines for various infectious diseases |
| FY2019 | FY2021 | Manabu Ato | National Institute of Infectious Diseases | Director | Study of antitoxin/antivenom therapy and replacement for humanized monoclonal antibodies |
| FY2019 | FY2021 | Masamichi Muramatsu | National Institute of Infectious Diseases | Director | Establishment of infection systems for viruses that are difficult to replicate in vitro and in vivo, and its application to the development of novel diagnosis, treatment and prevention methods |
| FY2019 | FY2021 | Makoto Kuroda | National Institute of Infectious Diseases | Director | Study of development of genome-based comprehensive and rapid pathogen detection system |
| FY2019 | FY2021 | Tadaki Suzuki | National Institute of Infectious Diseases | Chief | Development of pathological diagnostic methods for congenital infections and unexplained illness of possible infectious etiology |
| FY2019 | FY2021 | Yasushi Kawaguchi | The University of Tokyo | Professor | Establishment of novel methods for decoding viral protein coding genes |
| FY2019 | FY2021 | Tomomi Nakahara | National Cancer Center | Staff scientist | Development of genome editing based therapy of papillomavirus infected lesions with all in one adenovirus vectors expres sing super multicopy guide RNA and Cas9 nickase |
| FY2019 | FY2021 | Shinji Saito | National Institute of Infectious Diseases | Postdoctoral fellow | Escape mechanism of influenza virus from anti-HA stem antibody and the application of escape mutant viruses |
| FY2019 | FY2021 | Yuki Furuse | Kyoto University | Project Assistant Professor | Epidemiological and virological study of severe RS virus infection |
| FY2019 | FY2021 | Moi Meng Ling | Nagasaki University | Associate Professor | Study of neutralizing antibody repertoire in modulating dengue protection for vaccination strategies |
Last updated 07/17/19